The Patent Finder

Bayer Pharmaceuticals Corporation

Also on record
Records under this name other than patents Bayer Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Bayer Pharmaceuticals Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,612,925Double-Side Image Scanner and Scanning Method of the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,124,782Process for the Preparation of 4-{4-[({[4-Chloro-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-Carboxamide
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,737,488Pharmaceutical Composition for the Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,637,553Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,796,250Diaryl ureas for diseases mediated by PDGFR
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 6,774,117MN gene and protein
Formerly held
Term ended
Term ended Aug 10, 2026 · USPTO record
Term endedTerm ended Aug 10, 2026USPTO record
US 7,563,791Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Formerly held
Term ended
Term ended Nov 1, 2025 · USPTO record
Term endedTerm ended Nov 1, 2025USPTO record
US RE46,856Substituted 2,3-Dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Formerly held
Lapsed on the fee record
Ended Jun 18, 2025 · Low confidence
Lapsed on the fee recordEnded Jun 18, 2025Low confidence
US 7,951,588Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells
Formerly held
Term ended
Term ended Feb 14, 2025 · High confidence
Term endedTerm ended Feb 14, 2025High confidence
US 7,511,041Fused Azole-Pyrimidine Derivatives
Formerly held
Term ended
Term ended May 13, 2024 · High confidence
Term endedTerm ended May 13, 2024High confidence
10 of 244 patents shown.
Pro members see all 244.
Pro members: see all 244 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited